These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21255088)

  • 1. Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis.
    de Araujo E; Dessirier V; Laprée G; Valeyrie-Allanore L; Ortonne N; Stathopoulos EN; Bagot M; Bensussan A; Mockenhaupt M; Roujeau JC; Tsapis A
    Exp Dermatol; 2011 Feb; 20(2):107-12. PubMed ID: 21255088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.
    Nassif A; Bensussan A; Boumsell L; Deniaud A; Moslehi H; Wolkenstein P; Bagot M; Roujeau JC
    J Allergy Clin Immunol; 2004 Nov; 114(5):1209-15. PubMed ID: 15536433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chung WH; Hung SI; Yang JY; Su SC; Huang SP; Wei CY; Chin SW; Chiou CC; Chu SC; Ho HC; Yang CH; Lu CF; Wu JY; Liao YD; Chen YT
    Nat Med; 2008 Dec; 14(12):1343-50. PubMed ID: 19029983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionally active macrophage-derived myeloperoxidase in the skin of drug-induced toxic epidermal necrolysis.
    Paquet P; De Groote D; Piérard GE
    Dermatology; 2010; 220(3):201-7. PubMed ID: 20332596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the potential role of cytokines in toxic epidermal necrolysis.
    Nassif A; Moslehi H; Le Gouvello S; Bagot M; Lyonnet L; Michel L; Boumsell L; Bensussan A; Roujeau JC
    J Invest Dermatol; 2004 Nov; 123(5):850-5. PubMed ID: 15482470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
    Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
    Kassouf N; Thornhill MH
    Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.
    Nassif A; Bensussan A; Dorothée G; Mami-Chouaib F; Bachot N; Bagot M; Boumsell L; Roujeau JC
    J Invest Dermatol; 2002 Apr; 118(4):728-33. PubMed ID: 11918724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
    Konur A; Schulz U; Eissner G; Andreesen R; Holler E
    Br J Dermatol; 2005 Jun; 152(6):1134-42. PubMed ID: 15948973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Khalili B; Bahna SL
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal interleukin-8 and its receptor CXCR2 in drug-induced toxic epidermal necrolysis.
    Paquet P; Ribbens C; Piérard GE
    Clin Exp Dermatol; 2007 Nov; 32(6):728-32. PubMed ID: 17714530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidermal necrolysis: mechanisms of keratinocyte apoptosis].
    Roujeau JC; Gélard K; Bensussan A
    Med Sci (Paris); 2006 Feb; 22(2):188-91. PubMed ID: 16457761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological mechanisms of epidermal damage in toxic epidermal necrolysis.
    Tohyama M; Hashimoto K
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):376-82. PubMed ID: 22688730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
    Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
    Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic epidermal necrolysis: revisiting the tentative link between early apoptosis and late necrosis (review).
    Paquet P; Pierard GE
    Int J Mol Med; 2007 Jan; 19(1):3-10. PubMed ID: 17143541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major.
    Eidsmo L; Fluur C; Rethi B; Eriksson Ygberg S; Ruffin N; De Milito A; Akuffo H; Chiodi F
    Am J Pathol; 2007 Jan; 170(1):227-39. PubMed ID: 17200196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
    Chaturvedi V; Bodner B; Qin JZ; Nickoloff BJ
    J Dermatol Sci; 2006 Jan; 41(1):31-41. PubMed ID: 16289694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Toxic Epidermal Necrolysis.
    Harris V; Jackson C; Cooper A
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.